Single use components in biopharm – a regulatory perspective
February 4th, 2016 by Peter CalcottSingle use components have been used in operations for decades but their use is expanding rapidly. The agencies are taking a closer look. Just published an interesting article on the topic in BioPharmaceutical International . Enjoy the read